Triple-negative breast cancer (TNBC) lacks the three widely used diagnostic markers (human epidermal growth factor receptor 2, Her-2; progesterone receptor, PR; and estrogen receptor, ER). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.